Some business leaders might be tested in having to respond to the different challenges and crisis situations that have confronted WeightWatchers.

The CEO of WeightWatchers is abruptly out of a job amid growing uncertainty about the company's future following its pivot under her leadership to embracing weight-loss drugs. Why it matters: Tech executive Sima Sistani sent WeightWatchers in a new direction after she took over in early 2022,

Sima Sistani, CEO of WeightWatchers, announced her departure from the weight-loss company, which has struggled to adapt in the Ozempic era.

WW International , also known as WeightWatchers, said on Friday CEO Sima Sistani was stepping down and that insider Tara Comonte would succeed her on an interim basis.

WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two-year stint.

Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.

The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.